BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38623248)

  • 1. Focal-to-bilateral tonic-clonic seizures and High-grade CMV-infection are poor survival predictors in Tumor-related Epilepsy Adult-type diffuse gliomas-A single-center study and literature review.
    De la Cerda-Vargas MF; Pantalone MR; Söderberg Nauclér C; Medrano-Guzman R; Jauregui Renaud K; Nettel Rueda B; Reynoso-Sanchez MJ; Lopez-Quintana B; Rodriguez-Florido MA; Feria-Romero IA; Trejo-Rosales RR; Arreola-Rosales RL; Candelas-Rangel JA; Navarro-Dominguez P; Meza-Mata E; Muñoz-Hernandez MA; Segura-Lopez FK; Gonzalez-Martinez MDR; Delgado-Aguirre HA; Sandoval-Bonilla BA
    Heliyon; 2024 Apr; 10(7):e28555. PubMed ID: 38623248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.
    Mazzucchi E; Vollono C; Pauletto G; Lettieri C; Budai R; Gigli GL; Sabatino G; La Rocca G; Skrap M; Ius T
    J Neurol; 2022 May; 269(5):2627-2633. PubMed ID: 34693462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the type of seizure influence heart rate variability changes?
    Faria MT; Rodrigues S; Campelo M; Dias D; Rego R; Rocha H; Sá F; Tavares-Silva M; Pinto R; Pestana G; Oliveira A; Pereira J; Cunha JPS; Rocha-Gonçalves F; Gonçalves H; Martins E
    Epilepsy Behav; 2022 Jan; 126():108453. PubMed ID: 34864377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug reduction and increased risk of stimulation-evoked focal to bilateral tonic-clonic seizure during cortical stimulation in patients with focal epilepsy.
    Hampel KG; Gómez-Ibáñez A; Garcés-Sánchez M; Hervás-Marín D; Cano-López I; González-Bono E; Conde-Sardón R; Gutiérrez-Martín A; Villanueva V
    Epilepsy Behav; 2018 Mar; 80():104-108. PubMed ID: 29414538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Prognosis of Tumor-Related Epilepsy During Tumor Evolution in Patients With
    Pallud J; Roux A; Moiraghi A; Aboubakr O; Elia A; Guinard E; Oppenheim C; Tauziede-Espariat A; Parraga E; Gavaret M; Chrètien F; Huberfeld G; Zanello M
    Neurology; 2024 Jan; 102(1):e207902. PubMed ID: 38165369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma features and seizure control during long-term follow-up.
    Ollila L; Roivainen R
    Epilepsy Behav Rep; 2023; 21():100586. PubMed ID: 36712600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
    Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
    Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis.
    Moseley BD; Dimova S; Elmoufti S; Laloyaux C; Asadi-Pooya AA
    Epilepsy Res; 2021 Oct; 176():106694. PubMed ID: 34218211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    Li L; Fang S; Li G; Zhang K; Huang R; Wang Y; Zhang C; Li Y; Zhang W; Zhang Z; Jin Q; Zhou D; Fan X; Jiang T
    J Neurosurg; 2022 Jan; 136(1):67-75. PubMed ID: 34243149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-seizure medications and efficacy against focal to bilateral tonic-clonic seizures: A systematic review with relevance for SUDEP prevention.
    Cutillo G; Tolba H; Hirsch LJ
    Epilepsy Behav; 2021 Apr; 117():107815. PubMed ID: 33640562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of brain functional network and alertness changes in temporal lobe epilepsy with and without focal to bilateral tonic-clonic seizures.
    Nie L; Jiang Y; Lv Z; Pang X; Liang X; Chang W; Zheng J
    BMC Neurol; 2022 Jan; 22(1):14. PubMed ID: 34996377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can semiology differentiate between bilateral tonic-clonic seizures of focal-onset and generalized-onset? A systematic review.
    Christie H; D'Souza W; Cook M; Seneviratne U
    Epilepsy Behav; 2021 Mar; 116():107769. PubMed ID: 33556863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.
    Zhang ZY; Chan AK; Ding XJ; Qin ZY; Hong CS; Chen LC; Zhang X; Zhao FP; Wang Y; Wang Y; Zhou LF; Zhuang Z; Ng HK; Yan H; Yao Y; Mao Y
    Oncotarget; 2015 Sep; 6(28):24871-83. PubMed ID: 26314843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.
    Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M
    Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.
    Mehndiratta MM; Gulhane M; Jabeen SA; Patten A; Dash A; Malhotra M
    Epilepsia Open; 2021 Mar; 6(1):90-101. PubMed ID: 33681652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
    Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M
    Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse low grade glioma after the 2016 WHO update, seizure characteristics, imaging correlates and outcomes.
    Roberts M; Northmore T; Shires J; Taylor P; Hayhurst C
    Clin Neurol Neurosurg; 2018 Dec; 175():9-15. PubMed ID: 30292978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies.
    Piña-Garza JE; Villanueva V; Rosenfeld W; Yoshinaga H; Patten A; Malhotra M
    Epilepsy Behav; 2022 Oct; 135():108901. PubMed ID: 36122531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.